PetVivo Holdings, Inc. to Exhibit and Dr. Erik Kleeman of Ethos Veterinary Health to Present Canine Study Results at the Veterinary Orthopedic Society Annual Conference
March 10 2023 - 8:00AM
PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or
“PetVivo") an emerging biomedical device company focused on the
commercialization of innovative medical devices and therapeutics
for companion animals announced today it will be exhibiting at the
Veterinary Orthopedic Society (“VOS”) annual conference to be held
March 11th to Marth 18th, 2023 at the Yellowstone Conference Center
in Big Sky, Montana.
PetVivo intends to exhibit its lead product,
SPRYNG™ with OsteoCushion™ Technology, a medical device injection
of sterilized, extra-cellular matrix microparticles that are
lubricious and spongy used in the treatment of lameness and other
joint related afflictions, such as osteoarthritis. The VOS plays
host to many of the top industry professionals involved in
veterinary orthopedics.
"We are incredibly excited to showcase our
innovative product for the management of lameness, Spryng™ with
OsteoCushion™ Technology to the veterinary professionals at VOS,"
said John Lai, Chief Executive Officer, at PetVivo Holdings, Inc.
"We invite all VOS annual meeting attendees to stop by our PetVivo
booth to learn more."
Furthermore, Erik Kleemam DVM, MPH, of Ethos
Veterinary Health, will be a presenter for the 2023 VOS Annual
Conference in Big Sky, Montana. Dr. Kleeman will be presenting on
“Evaluating the Benefit and Tolerability of an Intra-Articular
Injection of a Collagen-Elastin Biomaterial into the Stifle Joint
of Dogs with Suspected Cruciate Ligament Rupture.” If you would
like to attend the presentation by Dr. Kleeman, the details are
provided below.
For more information about PetVivo Holdings,
Inc. please contact info1@petvivo.com or visit
https://petvivo.com/
Conference Exhibit Details:
Veterinary Orthopedic Society Annuual
Conference
Dates: Sunday, March 12, 2023 – Thursday, March
16, 2023
Location: Yellowstone Conference Center in Big
Sky, Montana
Dr. Erik Kleeman Presentation
Schedule:
Presentation Title: Evaluating the Benefit and
Tolerability of an Intra-Articular Injection of a Collagen-Elastin
Biomaterial into the Stifle Joint of Dogs with Suspected Cruciate
Ligament Rupture
Presentation Date: Friday, March 17: 7:30 a.m. -
7:45 a.m.
Location for Presentation: Yellowstone
Conference Center, Movora Lecture Hall - Missouri Ballroom in Big
Sky, Montana
About PetVivo Holdings,
Inc.
PetVivo Holdings Inc. (NASDAQ: PETV & PETVW)
is an emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for
the treatment of animals and people. A portfolio of nineteen
patents protects the Company's biomaterials, products, production
processes and methods of use. The Company’s lead product SPRYNG™
with OsteoCushion™ technology, a veterinarian-administered,
intraarticular injection for the management of lameness and other
joint related afflictions, including osteoarthritis, in dogs and
horses, is currently available for commercial sale.
For more information about PetVivo Holdings,
Inc. and our revolutionary product, Spryng with OsteoCushion
Technology, please contact info1@petvivo.com or visit
https://petvivo.com/
CONTACT:John Lai, CEOPetVivo Holdings,
Inc.Email: info1@petvivo.com(952) 405-6216
Forward-Looking Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements are
based on information currently available to the Company and its
current plans or expectations and are subject to a number of
uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2022 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jun 2024 to Jul 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2023 to Jul 2024